At ASCO 2026 in Chicago, ASCO 2026, Wondercel Therapeutics, founder Frank Fan, also the inventor of Carvykti, presented early clinical and manufacturing data on a novel allogeneic CAR-T cell therapy platform called Revo-U. The approach aims to overcome key GMP
